Published in J Hepatol on February 08, 2006
The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery (2009) 1.39
Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol (2009) 1.23
Functional anatomy of normal bile ducts. Anat Rec (Hoboken) (2008) 0.96
Update on Sclerosing Cholangitis in Critically Ill Patients. Viszeralmedizin (2015) 0.93
Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients. Crit Care (2015) 0.86
Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation. World J Gastroenterol (2014) 0.80
Sclerosing Cholangitis: Clinicopathologic Features, Imaging Spectrum, and Systemic Approach to Differential Diagnosis. Korean J Radiol (2016) 0.79
Bevacizumab to Treat Cholangiopathy in Hereditary Hemorrhagic Telangiectasia: Be Cautious: A Case Report. Medicine (Baltimore) (2015) 0.75
Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media- a single center retrospective study. BMC Gastroenterol (2017) 0.75
Secondary sclerosing cholangitis in critically ill patients: current perspectives. Clin Exp Gastroenterol (2017) 0.75
Vascular disorders of the liver. Hepatology (2009) 5.38
The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol (2013) 4.05
Budd-Chiari syndrome: a review by an expert panel. J Hepatol (2003) 3.69
Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol (2010) 2.41
Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodes. Liver Transpl (2010) 1.81
Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol (2006) 1.66
Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatology (2015) 1.62
Management of hepatic vascular diseases. J Hepatol (2012) 1.61
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology (2004) 1.57
Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology (2005) 1.52
MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours. Eur Radiol (2012) 1.47
Budd-Chiari syndrome. Semin Liver Dis (2008) 1.27
Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Hepatology (2012) 1.24
Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology (2007) 1.21
Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis. J Gastroenterol Hepatol (2002) 1.20
Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology (2011) 1.14
Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int (2011) 1.04
Coagulation disorders in patients with cirrhosis and severe sepsis. Liver Int (2003) 1.02
Ischemic cholangiopathy. Semin Liver Dis (2008) 0.99
Clinical characteristics and outcome of patients with cirrhosis and refractory ascites. Liver Int (2004) 0.93
Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trail. Liver Int (2006) 0.87
Prospective evaluation of the management of hepatocellular carcinoma in the elderly. Dig Liver Dis (2011) 0.85
Portal vein thrombosis: a predictable milestone in cirrhosis? J Hepatol (2009) 0.84
Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome? Liver Transpl (2007) 0.79
Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue. Hepatology (2008) 0.79
Risk factors for Clostridium difficile infection in a hepatology ward. Infect Control Hosp Epidemiol (2007) 0.75
The Budd-Chiari syndrome. N Engl J Med (2004) 0.75